SIRO implements Oracle application

BANGALORE, INDIA: Clinical research organization Clinpharm Private Limited (SIRO) has decided to implement a new IT framework comprising Oracle’s Life Sciences Applications (OLSA) and other Oracle applications running on Sun Microsystems’ hardware platform.

This IT infrastructure will be implemented by DBMS Consulting, a member of the Oracle Partner Network.

A release from Oracle said that this new IT system is expected to bring about greater efficiency and increased customer focus in SIRO’s operations.

The new system will touch and impact over 500 SIRO clinical researchers involved in more than 150 clinical studies.

Established in 1996, SIRO offers end-to-end clinical research services, with clinical trials management and clinical data management as its core operations.

SIRO required a solution that was robust, with industry’s best practices that could scale up rapidly to meet the company’s growth demands.

SIRO will implement Oracle’s Life Sciences Applications as a complete electronic information environment, for gathering and reporting clinical data.

Besides reducing errors, Oracle’s Life Sciences Applications will enable SIRO to speed information gathering and reduce the need for paper documentation.

Chetan Tamhankar, Chief Operating Officer, SIRO said, “Oracle will help us deliver a powerful combination of technology and comprehensive business applications, and key functionality built specifically to address the nuances of the CRO industry.”

“We will be able to track, monitor and ensure optimum utilization of our resources across locations. We found the combination of Oracle’s Life Sciences Applications and Sun hardware best suited to our rapid growth requirements and our needs for continued regulatory compliance.,” said Vishnu Banka, Senior Vice President, Finance and Corporate Strategy, SIRO.